226 related articles for article (PubMed ID: 2480431)
1. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
3. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
Warner AA; Pettenati MJ; Burton BK
Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of structural abnormalities.
Sanders RC
Curr Opin Obstet Gynecol; 1991 Apr; 3(2):259-65. PubMed ID: 1717021
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
Kaffe S; Hsu LY
Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
[TBL] [Abstract][Full Text] [Related]
7. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
9. High maternal serum alpha-fetoprotein levels during the 2nd trimester of pregnancy: diagnostic approach.
Periti E; Cariati E; Brizzi L; Nannini R; Paladini S
J Nucl Med Allied Sci; 1989; 33(3 Suppl):81-4. PubMed ID: 2480430
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
Megerian G; Godmilow L; Donnenfeld AE
Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
[TBL] [Abstract][Full Text] [Related]
11. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
Cariati E; Brizzi L; Periti E
J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
[TBL] [Abstract][Full Text] [Related]
12. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
13. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
14. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
[TBL] [Abstract][Full Text] [Related]
15. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosomal abnormalities.
Stiller RJ; de Regt RH; Suntag S; Baumgarten A; Hobbins JC; Mahoney MJ
Obstet Gynecol; 1990 Jun; 75(6):994-7. PubMed ID: 1692983
[TBL] [Abstract][Full Text] [Related]
16. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
[TBL] [Abstract][Full Text] [Related]
17. Local norms of maternal serum alpha-fetoprotein values in early second trimester: a prelude to a Down's syndrome screening programme incorporating maternal serum alpha-fetoprotein values.
Lai FM; Yeo SH; Yo SL; Tan IK
Singapore Med J; 1991 Apr; 32(2):134-7. PubMed ID: 1710394
[TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
19. [Significance of pathological alpha-1-fetoprotein levels in the framework of prenatal diagnosis].
Casper F; Möbus V; Wellek S; Gehm D; Seufert R; Brockerhoff P; Kreienberg R
Z Geburtshilfe Perinatol; 1992; 196(1):7-10. PubMed ID: 1372459
[TBL] [Abstract][Full Text] [Related]
20. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
Aitken DA; Crossley JA
Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
